Drug Pipeline

Fosigotifator Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT04297683
HEALEY ALS Platform Trial - Master Protocol		 Trial sites expanded: 78 -> 81 locations
Active Studies by Phase
Phase 2/3
1
Phase 1/2
1
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT04297683 HEALEY ALS Platform Trial - Master Protocol Amyotrophic Lateral Sclerosis Recruiting
Phase 1/2
NCT05757141 An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White… Vanishing White Matter Disease Recruiting
Early Phase 1
NCT07272525 Research Study for Single-Patient Treatment of Cree Leukoencephalopathy/Vanishing White… Cree Leukoencephalopathy Active, Not Recruiting
Not specified
NCT07300397 Single Patient Investigational Treatment for Cree Leukoencephalopathy Cree Leukoencephalopathy Active, Not Recruiting
Sponsors Running Fosigotifator Trials
McGill University Health Centre/Research Institute of the McGill University Health Centre (2) Merit E. Cudkowicz, MD (1) Calico Life Sciences LLC (1)
Disease Areas
ALS (1)
Get alerts when Fosigotifator trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free